Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Glucose and Maltodextrin market in this environment.
In terms of revenue, this research report indicated that the global Glucose and Maltodextrin market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Glucose and Maltodextrin industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The ? ? Agrana Investment Corp aims at producing XX Glucose and Maltodextrin in 2020, with XX % production to take place in global market, ? ? Archer Daniels Midland Company accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Glucose and Maltodextrin Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Glucose and Maltodextrin Market?
Agrana Investment Corp
Archer Daniels Midland Company
Avebe U.A.
Cargill
Incorporated
Emsland-Starke Gmbh
Grain Processing Corporation
Ingredion Incorporated
Penford Corporation
Roquette Freres
...
Major Type of Glucose and Maltodextrin Covered in XYZResearch report:
Glucose
Maltodextrin
Application Segments Covered in XYZResearch Market
Paper & Pulp
Cosmetics
Pharmaceuticals
Food & Beverages
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Glucose and Maltodextrin Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Glucose -Product Introduction and Major Manufacturers
1.1.2 Maltodextrin -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Glucose and Maltodextrin Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Glucose and Maltodextrin Market
3.1.1 Top Companies leading Glucose and Maltodextrin Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Glucose and Maltodextrin Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Glucose and Maltodextrin Market
3.2.1 Top Companies leading Glucose and Maltodextrin Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Glucose and Maltodextrin Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Glucose and Maltodextrin Market
3.3.1 Top Companies leading Glucose and Maltodextrin Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Glucose and Maltodextrin Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Glucose and Maltodextrin Market
3.4.1 Top Companies leading Glucose and Maltodextrin Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Glucose and Maltodextrin Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Glucose and Maltodextrin Market
3.5.1 Top Companies leading Glucose and Maltodextrin Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Glucose and Maltodextrin Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Glucose and Maltodextrin Market
3.6.1 Top Companies leading Glucose and Maltodextrin Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Glucose and Maltodextrin Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Glucose and Maltodextrin Market
3.7.1 Top Companies leading Glucose and Maltodextrin Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Glucose and Maltodextrin Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Glucose and Maltodextrin Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Glucose and Maltodextrin Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Glucose and Maltodextrin Sales and Growth Rate (2021-2026)
5.2 Global Glucose and Maltodextrin Sales Value and Growth Rate (2021-2026)
6 Glucose and Maltodextrin Competitive Analysis
6.1 Agrana Investment Corp
6.1.1 Agrana Investment Corp Company Profiles
6.1.2 Agrana Investment Corp Product Introduction
6.1.3 Agrana Investment Corp Glucose and Maltodextrin Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Archer Daniels Midland Company
6.2.1 Archer Daniels Midland Company Company Profiles
6.2.2 Archer Daniels Midland Company Product Introduction
6.2.3 Archer Daniels Midland Company Glucose and Maltodextrin Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Avebe U.A.
6.3.1 Avebe U.A. Company Profiles
6.3.2 Avebe U.A. Product Introduction
6.3.3 Avebe U.A. Glucose and Maltodextrin Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Cargill
6.4.1 Cargill Company Profiles
6.4.2 Cargill Product Introduction
6.4.3 Cargill Glucose and Maltodextrin Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Incorporated
6.5.1 Incorporated Company Profiles
6.5.2 Incorporated Product Introduction
6.5.3 Incorporated Glucose and Maltodextrin Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Emsland-Starke Gmbh
6.6.1 Emsland-Starke Gmbh Company Profiles
6.6.2 Emsland-Starke Gmbh Product Introduction
6.6.3 Emsland-Starke Gmbh Glucose and Maltodextrin Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Grain Processing Corporation
6.7.1 Grain Processing Corporation Company Profiles
6.7.2 Grain Processing Corporation Product Introduction
6.7.3 Grain Processing Corporation Glucose and Maltodextrin Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Ingredion Incorporated
6.8.1 Ingredion Incorporated Company Profiles
6.8.2 Ingredion Incorporated Product Introduction
6.8.3 Ingredion Incorporated Glucose and Maltodextrin Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Penford Corporation
6.9.1 Penford Corporation Company Profiles
6.9.2 Penford Corporation Product Introduction
6.9.3 Penford Corporation Glucose and Maltodextrin Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
6.10 Roquette Freres
6.10.1 Roquette Freres Company Profiles
6.10.2 Roquette Freres Product Introduction
6.10.3 Roquette Freres Glucose and Maltodextrin Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
7 Conclusion
Market Overview
The Asia Pacific Vital Sign Monitoring Devices Market is set to experience significant expansion from 2024 to 2034. This growth is driven by the increasing prevalence of chronic diseases, rising health awareness, and advancements in monitoring technology. The market is p...
Market Overview
The Europe Vital Sign Monitoring Devices Market is projected to witness significant growth from 2024 to 2034, driven by increasing demand for continuous health monitoring, rising prevalence of chronic diseases, and the expanding elderly population. The market is anticipa...
Market Overview
The North America Vital Sign Monitoring Devices Market is anticipated to witness robust growth between 2024 and 2034, driven by an increasing prevalence of chronic diseases, rising health awareness, and the growing adoption of remote patient monitoring technologies. The ...
Market Overview
The Global Vital Sign Monitoring Devices Market is anticipated to experience significant growth from 2024 to 2034, driven by technological advancements, increasing prevalence of chronic diseases, and the growing demand for home healthcare solutions. Valued at USD XX.XX b...
The global Self Blood Glucose Monitoring market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market player...
The global Digestion Resistant Maltodextrin market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pla...
The global Glucose, Dextrose, and Maltodextrin market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market ...
The global Self-monitoring Blood Glucose Devices market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help marke...
The global Blood Glucose Testing Equipment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market play...
The global Blood Glucose Monitoring Systems market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pla...